Efficacy of a New Nanoemulsion Artificial Tear in Dry Eye Disease Management

The study focuses on testing a new type of eye drop called nanoemulsion artificial tears, specifically Systane Complete, for people suffering from dry eye disease. The goal is to see how effective these eye drops are in improving both how patients feel and the actual health of their eyes. People with dry eye often struggle with discomfort and irritation, and this study aims to discover if this new treatment can offer better relief than existing options by improving symptoms and eye health indicators. Participants in the study will use the Systane Complete eye drops four times a day for three months. To track progress, they will attend follow-up appointments after two weeks and again after three months. Researchers will look at both how participants report their symptoms and objective measures, like how long the tear film lasts on the eye and the condition of the eye surface. Secondary evaluations, such as images of the meibomian glands and the thickness of the eye's lipid layer, will also be assessed. This approach helps determine the comprehensive impact of the treatment on dry eye symptoms and eye health.